Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences
" "
Safety Alerts
August 4, 1999

SmithKline Beecham Recalls Requip® Tablets

Philadelphia, PA (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that SmithKline Beecham Pharmaceuticals is recalling Requip® Tablets because the tablet fades from pale blue to white.

Requip® Tablets (Ropinirole HCl), 5 mg, in 100 tablet bottles, Rx taken orally for the treatment of Parkinson's disease. NDC #0007-4894-20.

Recall #D-293-9.

Lot Numbers: 680930 EXP 4/30/99, 680940 EXP 7/31/99,720510 EXP 11/30/99.

SmithKline Beecham Pharmaceuticals, Crawlely, West Sussex.

SmithKline Beecham Pharmaceuticals, Philadelphia, Pennsylvania, by letter sent on March 3, 1999, and June 4, 1999. Firm-initiated recall ongoing.


Approximately 14,033 bottles remained on market at time of recall initiation.


The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.